Especially recommended for: Vascular Lesions, Scars, Psoriasis, Anti-Aging & Wrinkles, Pigmented Lesions
Ideal emission at 595 nm
International scientific literature consider 595 nm the best wavelength to be absorbed by hemoglobin for both its selective and protective action.
Exclusive RightLight™ Technology (DEKA patent)
The special ligth is an exclusive DEKA patent and makes it possible to eliminate problems encountered when using laser dye laser on targets with lower absorption.
Wide Range of applications
Synchro VasQ is able to treat all vascular lesions: From the deepest and thickest to more superficial ones.
Synchro VasQ: An Effective Laser Source for Every Treatment
In international scientific literature Dye laser is the most effective wavelenght (595nm) for absorption in haemoglobin. Synchro VasQ, with its proper features and introducing the new RightLight™ Technology, represents a really unique real novelty in the dye laser world, guaranteeing at the same time a selective action and protection of the dermal structures surrounding the lesion.
Synchro VasQ treats a large number of vascular lesions and can also be used in the treatment of psoriasis, warts, scars and acne, without the annoying problem of post-treatment purpura (energy is released through micropulses).
The greater amount of energy available makes it possible to use a maximum spot size of 12 mm, guaranteeing treatment speed and an improved therapeutic approach.
DEKA M.E.L.A. S.r.l.
Via Baldanzese, 17 - 50041
Calenzano (FI), Italy
+39 055 8874942
+39 055 8832884
VAT IT04190470486REA Firenze: 425321
Please be aware that some of the brochures / information / intended uses / configurations / accessories mentioned on the site are not available in the USA and its administrative territories.
If you are a US citizen click here.